What to expect from targeted therapy for leukaemia

Leukaemia includes different diseases, so the relevant cell marker and treatment goal matter. Laboratory tests on blood or bone marrow can help identify a target. Depending on the type, treatment may be a tablet, an infusion, or part of a combination plan.

Blood counts are checked regularly to see how the leukaemia is responding and whether normal blood-making is being affected. Other tests may monitor liver function, kidney function or treatment-specific effects. Some medicines continue for a defined course, while others are taken longer if they remain helpful and tolerated.

Take medicine exactly as prescribed and ask what to do after a missed dose or vomiting. Avoid starting supplements or new medicines without a pharmacist or oncology review. Keep your temperature-taking instructions available and report infection symptoms early, because leukaemia and its treatment can reduce protective blood cells.

Attend blood tests even when symptoms are mild. Use the mouth care, food safety and hand hygiene advice supplied by your team. Tell them about bruising, bleeding, breathlessness, paleness, severe fatigue, nausea, diarrhoea or new pain.

Call your treatment team urgently for a fever, chills, new cough, painful urination, bleeding, black stools, severe headache or worsening breathlessness. Go to emergency care for uncontrolled bleeding, collapse, confusion, severe breathing difficulty or sudden weakness.

Which marker is being targeted? What blood-count changes are expected? What temperature or infection symptoms require an urgent call? How will response be confirmed? Are there medicines or foods I should avoid?